Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects
|2||Active, not recruiting||
18-Month Study of Curcumin
A Phase III Trial of Nilvadipine to Treat Alzheimer's Disease
Web-based Psycho-Educational Program to Support Carers of Alzheimer's Patients
Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the Brain
† Study has passed its completion date and status has not been verified in more than two years.